ABIRATERONE ACETATE vs INMAZEB

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. ABIRATERONE ACETATE and INMAZEB are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	ABIRATERONE ACETATE	INMAZEB
Rating	72/100	70/100
Pharmacy pays	~$25.50 /30	—
Type	RX	RX
Active ingredient	ABIRATERONE ACETATE	ATOLTIVIMAB AND ODESIVIMAB AND MAFTIVIMAB
Manufacturer	Hikma	Regeneron Pharmaceuticals
Dosage forms	Tablet	Injectable
Drug class	Cytochrome P450 17a1 Inhibitor	—
Boxed warning	None	None
Treats	Castration-Resistant Prostatic Neoplasms	—

abiraterone acetate inmazeb

Rating

72/100

70/100

Pharmacy pays

~$25.50 /30

—

Type

Active ingredient

ABIRATERONE ACETATE

ATOLTIVIMAB AND ODESIVIMAB AND MAFTIVIMAB

Manufacturer

Hikma

Regeneron Pharmaceuticals

Dosage forms

Tablet

Injectable

Drug class

Cytochrome P450 17a1 Inhibitor

—

Boxed warning

None

Treats

Castration-Resistant Prostatic Neoplasms

—

Frequently asked questions

Which is better-rated, Abiraterone Acetate or Inmazeb?

By our independent rating, Abiraterone Acetate scores higher — 3.6 vs 3.5 out of 5 for Inmazeb. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Abiraterone Acetate and Inmazeb?

Abiraterone Acetate contains Abiraterone Acetate, while Inmazeb contains Atoltivimab and Odesivimab and Maftivimab — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.